The oscillating positive expiratory pressure (OPEP) device market is on its way to perceiving an escalation in value, from USD 151.30 million in 2024 up to USD 263.40 million by 2034. The updated report infers a CAGR of 5.70% between 2024 and 2034, reflecting a robust OPEP device market growth.
The stimulus guiding the oscillating positive expiratory pressure device market is the heightening occurrence of chronic lung disorders and booming innovation.
The soaring elderly population together with the prevalence of chronic diseases thrust the sales of oscillating positive expiratory pressure (OPEP) devices. The skyrocketing pervasiveness of COPD along with asthma is another catalyst for the market.
| Attributes | Details |
|---|---|
| Market Value for 2024 | USD 151.30 million |
| Market Value for 2034 | USD 263.40 million |
| Market CAGR from 2024 to 2034 | 5.70% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Details |
|---|---|
| Market Value for 2019 | USD 110.40 million |
| Market Value for 2023 | USD 143.40 million |
| Market CAGR from 2019 to 2023 | 5.40% |
The segmented oscillating positive expiratory pressure (OPEP) device market analysis is included in the following subsection. Based on comprehensive studies, the mouthpiece PEP devices sector is dominating the product type category. Followed by, the COPD segment taking precedence over the indication category.
| Segment | Mouthpiece PEP Devices |
|---|---|
| Share (2024) | 96.80% |
Mouthpiece PEP devices provide targeted airflow control, surging the user comfort and efficacy which escalates the demand. The mobility and easy usage make mouthpiece PEP devices preferable for on-the-go respiratory treatment.
The strengthened patient compliance because of the direct therapy delivery via mouthpiece PEP devices ramps up the adoption. General practitioners prefer mouthpiece PEP devices owing to accurate pressure adjustment and monitoring abilities.
The cost-effectiveness and productivity of mouthpiece PEP devices position them as a supreme alternative for medical facilities.
| Segment | COPD |
|---|---|
| Share (2024) | 33.70% |
COPD is found increasing globally, increasing the demand for OPEP devices. The surging awareness among medical care providers about the potency of oscillating positive expiratory pressure in handling COPD.
Continuous advancement and product innovation sustain precisely to COPD patients, garnering market leadership. The oscillating positive expiratory pressure device is a non-invasive and economical solution for patients suffering from COPD, intensifying the adoption.
Principal Consultant
The OPEP device market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for oscillating positive expiratory pressure devices.
Sales Analysis of OPEP Device in North America
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 5.40% |
| Canada | 4.50% |
The technical development and the presence of vital producers aid the growth of the OPEP device market in the United States. The surging healthcare expenses and promising reimbursement policies soar the adoption of OPEP devices in the United States.
Telemedicine development and the strengthening trend of home healthcare ushered in the demand for OPEP devices in the United States. Partnerships between pharmaceutical companies and oscillating positive expiratory pressure (OPEP) device vendors intensify market growth in the United States.
Government schemes that stimulate respiratory health awareness and management encourage the adoption of oscillating positive expiratory pressure (OPEP) devices in Canada. The market is depicted by the presence of local and international OPEP device providers, sustaining competition and development.
The amplifying healthcare investments and innovations in medical technology prompt the growth of the OPEP device market in Canada. The inclination toward personalized healthcare and patient-centric treatment approaches intensifies the demand for OPEP devices in the healthcare landscape of Canada.
Opportunities for OPEP Devices in Europe
| Countries | CAGR (2024 to 2034) |
|---|---|
| Germany | 5.60% |
| United Kingdom | 5.40% |
| Italy | 5.20% |
| France | 5.00% |
| BENELUX | 4.60% |
| Spain | 4.60% |
| Russia | 4.10% |
The adoption of telemedicine and digital therapeutics platforms accelerates remote monitoring and management of pulmonary disease, upsurging the sales of oscillating positive expiratory pressure (OPEP) devices in Germany.
Patient preference and satisfaction with OPEP therapy approaches augment the adoption among people with respiratory ailments in Germany. The pervasiveness of chronic respiratory diseases thrusts OPEP device market growth in Germany.
Strengthening demand for OPEP devices in home healthcare settings amplifies the United Kingdom market growth. National healthcare schemes concentrating on respiratory health catapult the OPEP device adoption in the United Kingdom.
Mergers of OPEP devices into exhaustive respiratory care schemes ameliorate patient health results and ramp up the United Kingdom's oscillating positive expiratory pressure (OPEP) device market growth.
OPEP device market experiences swift growth because of spurring pollution levels and the advent of respiratory disorders. The impact of key opinion leaders and medical associations escalates consciousness and adoption of OPEP devices in Italy.
The towering stress on preventive care and patient awareness aids the oscillating positive expiratory pressure device market expansion in Italy.
Opportunities in the Asia Pacific OPEP Device Industry
| Countries | CAGR (2024 to 2034) |
|---|---|
| China | 6.00% |
| Japan | 5.60% |
The stretching middle-class population and heightening precedence of respiratory illnesses thrust the demand for oscillating positive expiratory pressure (OPEP) devices in China. The escalating healthcare charges coupled with the pre-eminence on preventive healthcare assists the oscillating positive expiratory pressure device market growth in China.
Government strategies directed at amending respiratory care and curbing the burden of respiratory disorders facilitate the OPEP device market in China. Technological progression and a spurring medical device sector in China present influential growth opportunities for OPEP device producers.
The adoption of OPEP devices for pediatric and geriatric populations is gaining traction in Japan creating a substantial market, ushered by the productive respiratory therapy solutions demand. The soaring healthcare costs, coupled with a strong emphasis on research and development, bolsters the expansion of the OPEP device market in Japan.
Japan healthcare system emphasizes on patient-centric care and groundbreaking developments strengthen the sales of oscillating positive expiratory pressure (OPEP) devices. The rigid regulatory landscape warrants product quality and protection, inculcating confidence in healthcare practitioners and catapulting the adoption of OPEP devices in Japan.
The vital oscillating positive expiratory pressure device manufacturers compete for leadership in a landscape indicated by innovation and healthcare quality improvement. The oscillating positive expiratory pressure device vendors portray diverse expertise, each devises strengths to the market.
While Smith’s Medical, Inc. and Allergan plc exhibit ascendancy through innovation and dependability, Monaghan Medical Corporation & Trudell Medical International showcase specialized solutions.
PARI GmbH and WyMedical Pty Ltd expand the portfolio of the landscape with their distinctive contributions to the oscillating positive expiratory pressure (OPEP) device industry, while R. Cegla GmbH & Co. KG and D-R Burton Healthcare proffer expertise in certain niche segments.
In this competitive terrain, AirPhysio and Medica Holdings, LLC. inculcate vitality into the market, nurturing a climate ideal for continuous innovations. As OPEP device manufacturers go through the shifting demands of healthcare, there are continuous advancements in the industry.
Noteworthy Observations
| Company | Monaghan Medical Corporation |
|---|---|
| Headquarter | United States |
| Recent Advancement |
|
| Company | Smith’s Medical, Inc. |
|---|---|
| Headquarter | United States |
| Recent Advancement |
|
| Company | AirPhysio |
|---|---|
| Headquarter | Australia |
| Recent Advancement |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The OPEP device market to hold a valuation of US$ 151.30 million in 2024.
The oscillating positive expiratory pressure device market has the potential to acquire worth of US$ 263.40 million by 2034.
The OPEP device market indicates a moderate CAGR of 5.70% through 2034.
From 2019 to 2023, the oscillating positive expiratory pressure device market evolved a 5.40% CAGR.
The mouthpiece PEP devices sector is slated to clutch a share of 96.80% in 2024.
The COPD sector to possess a share of 33.70% in 2024.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 5.1. Face Mask PEP Devices 5.2. Mouthpiece PEP Devices 5.3. Bottle PEP Devices 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication 6.1. COPD 6.2. Asthma 6.3. Atelectasis 6.4. Bronchitis 6.5. Bronchiectasis 6.6. Cystic Fibrosis 6.7. Others 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 7.1. Hospital Pharmacies 7.2. Retail Pharmacies 7.3. Online Pharmacies 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Smiths Medical, Inc. 18.2. Allergan plc 18.3. Monaghan Medical Corporation 18.4. PARI GmbH 18.5. WyMedical Pty Ltd 18.6. R. Cegla GmbH & Co. KG 18.7. D-R BURTON HEALTHCARE 18.8. AirPhysio 18.9. Medica Holdings, LLC. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Oscillating Positive Expiratory Pressure (OPEP) Device Market
